| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $611.6M | +26.8% |
| Cost of Revenue | $187.3M | +8.9% |
| Gross Profit | $424.3M | +36.8% |
| R&D Expense | $80.7M | +15.1% |
| SG&A Expense | $450.2M | +20.3% |
| Operating Income | -$136.2M | +21.5% |
| Interest Expense | $24.9M | +49.5% |
| Pre-tax Income | -$162.1M | +13.3% |
| Income Tax | $50K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $138.8M | -37.2% |
| Accounts Receivable | $83.0M | +14.3% |
| Inventory | $175.3M | +28.1% |
| Current Assets | $417.4M | -7.5% |
| Total Assets | $775.7M | -3.7% |
| Current Liabilities | $153.0M | -2.9% |
| Long-term Debt | $576.2M | +12.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.7M | +43.1% |
| Capital Expenditures | $83.2M | +3.4% |
| Investing Cash Flow | -$93.1M | +34.4% |
| Financing Cash Flow | $56.2M | -84.3% |
| Free Cash Flow | -$127.9M | +19.6% |
| +118.1% |
| Net Income | -$162.1M | +13.1% |
| EPS (Basic) | -$1.13 | +26.6% |
| EPS (Diluted) | -$1.13 | +26.6% |
| Stockholders' Equity |
| -$14.2M |
| -118.1% |